Martin K. (Casey) Childers, DO, PhD

"When we see the results of our research unfold into clinical trials where hope is transformed into a new lease on life, it is the ultimate definition of success."

Martin K. (Casey) Childers, DO, PhD

Chief Medical Officer

Casey Childers is a medical executive with experience leading translational and clinical development in AAV gene transfer for neuromuscular diseases and orphan diseases. Skilled in team build-out for executing translational programs in rare diseases, he joined AskBio in 2017 to oversee Medical Affairs.

Prior to that, Dr. Childers was a professor in the Department of Rehabilitation Medicine and a co-director of the Institute for Stem Cell and Regenerative Medicine at the University of Washington. His research focused on two areas of investigation: issues related to systemic gene replacement delivery in pre-clinical studies for patients with rare neuromuscular diseases, such as X-linked myotubular myopathy and, in other studies, his research used a “disease in a dish” approach with induced pluripotent stem cells to study heart disease in patients with Duchenne muscular dystrophy. Previously, Dr. Childers’ clinical medicine practice at the University of Washington Medical Center was dedicated to serving patients with neuromuscular diseases. Dr. Childers completed his graduate studies at Western University, College of Osteopathic Medicine, and University of Missouri-Columbia, Department of Physical Medicine & Rehabilitation and Department of Physiology.